Vimarsana
Biggest News Aggregation in the World

Page 24 - Device Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Device Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Device Designation Today - Breaking & Trending Today

Cognoa Appoints Pediatric Neurologist and AI in Healthcare Pioneer Dr. Sharief Taraman as CEO to Spearhead the Next Stage of the Company's Growth - Vimarsana News

Cognoa Appoints Pediatric Neurologist and AI in Healthcare Pioneer Dr. Sharief Taraman as CEO to Spearhead the Next Stage of the Company's Growth

/PRNewswire/ -- Cognoa, a pediatric behavioral health company, today announced the appointment of Dr. Sharief Taraman as Chief Executive Officer. Dr. Taraman...

Mayo Clinic venture Anumana acquires cardiac AI company NeuTrace - Vimarsana News

Mayo Clinic venture Anumana acquires cardiac AI company NeuTrace

NeuTrace focused on developing in-procedure AI tools for electrophysiology.

CytoSorbents Reports Third Quarter 2022 Financial and Operational Results - Vimarsana News

CytoSorbents Reports Third Quarter 2022 Financial and Operational Results

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CytoSorbents Reports Third Quarter 2022 Financial and Operational Results - Vimarsana News

CytoSorbents Reports Third Quarter 2022 Financial and Operational Results

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

CytoSorbents Reports Third Quarter 2022 Financial and Operational Results - Vimarsana News

CytoSorbents Reports Third Quarter 2022 Financial and Operational Results

CytoSorbents expects to achieve first milestone of the U.S. pivotal STAR-T Trial this monthPRINCETON, N.J., Nov. 3, 2022 /PRNewswire/ -- CytoSorbe...